Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-04

Clinical Trial Update: Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

This Phase 1 trial compared Adapalene Gel 0.3% to the Differin brand and to placebo for acne vulgaris. The study has completed and assessed safety and prelimina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene Gel 0.3% (adapalene)
  • DIFFERIN (ADAPALENE)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED